GlassScriptPhysician profile
Rachel Goodwin
NPI 1295266294
$73,872.51
in general payments reported to CMS, 2019-2025
24 companies · $2,450 in 2025
The $2,450 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $628 · 2021: $220 · 2022: $1,288 · 2023: $2,028 · 2024: $67K · 2025: $2,450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $60K · Food and Beverage: $7,454 · Travel and Lodging: $4,118 · Education: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $60,000.00 |
| Food and Beverage | $7,453.56 |
| Travel and Lodging | $4,117.94 |
| Education | $165.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $32,195.54 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Aurora Ev-Icd Mri Surescan |
| Abbott Laboratories | $17,976.79 | 2021-2025 | Mitraclip, Ensite Precision, Optis |
| Boston Scientific Corporation | $16,012.18 | 2023-2025 | Watchman Flx, Rotablator Rotational Atherectomy System Console Kit, Avvigo Guidance System |
| Edwards Lifesciences Corporation | $4,358.27 | 2024-2025 | Pascal, Evoque |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $786.73 | 2020-2023 | Lifevest |
| Abiomed | $421.25 | 2022-2024 | Impella |
| Biosense Webster, INC. | $320.47 | 2025 | Carto 3 |
| Shockwave Medical, INC | $307.98 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $293.78 | 2024 | (Ao0) Igt Devices Intracardiac, (Bh4) Igt Devices Undivided |
| Astrazeneca Pharmaceuticals LP | $251.34 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $217.72 | 2020-2023 | |
| Cardiva Medical, INC. | $168.72 | 2024-2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| W. L. Gore & Associates, INC. | $166.53 | 2023 | Gore Cardioform Septal Occluder |
| Terumo Medical Corporation | $110.15 | 2023 | Angio-Seal, Azur Cx Detachable |
| Chiesi USA, INC. | $72.00 | 2023 | Kengreal |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $48.00 | 2023 | Indigo System |
| Pfizer INC. | $34.45 | 2020-2022 | |
| Daiichi Sankyo INC. | $24.98 | 2023 | Injectafer |
| United Therapeutics Corporation | $19.84 | 2023 | Tyvaso |
| Alnylam Pharmaceuticals INC. | $19.10 | 2022 | |
| Abbvie INC. | $18.79 | 2025 | |
| Atricure, INC. | $17.35 | 2020 | |
| Kiniksa Pharmaceuticals, LTD. | $15.34 | 2023 | Arcalyst |
| Akcea Therapeutics, INC. | $15.21 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Goodwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.